Genus (GENSF) Stock Price, News & Analysis

Company Overview

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Key Stats

• Today's Range: $27.28 to $27.28
• 50-Day Range: $21.00 to $27.28
• 52-Week Range: $20.51 to $27.28
• Volume: 200 shs
• Average Volume: 567 shs
• Market Capitalization: N/A
• P/E Ratio: 57.30
• Dividend Yield: 0.61%
• Price Target: N/A
• Consensus Rating: N/A

Genus Stock Analysis - MarketRank™

Genus scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Genus.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Genus is 57.30, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.33.

Price to Earnings Ratio vs. Sector

The P/E ratio of Genus is 57.30, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.99.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Genus has a short interest ratio ("days to cover") of 28, which indicates bearish sentiment.

Change versus previous month

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Genus pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Genus does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Genus is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Genus has a short interest ratio ("days to cover") of 28, which indicates bearish sentiment.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Genus this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Genus insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 29.70% of the stock of Genus is held by institutions.

GENSF Stock Analysis - Frequently Asked Questions

How have GENSF shares performed this year?

Genus' stock was trading at $21.0050 at the beginning of the year. Since then, GENSF shares have increased by 29.9% and is now trading at $27.2760.
View the best growth stocks for 2025 here.

How do I buy shares of Genus?

Shares of GENSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:GENSF
• CIK: N/A
• Web: www.genusplc.com
• Phone: 441256347100
• Fax: N/A
• Employees: 3,500
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 57.30
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A